Abstract
To take advantage of solid-state properties, the nano spray-drying (NSD) technique was investigated as an innovative one-step method to produce solid lipid nanoparticles (SLN) in the form of a dry powder starting from a lipid/leucine O/W emulsion. Compritol was chosen as wall-forming lipid. Rapamycin (Rp) was employed as a model drug to be loaded into SLN. Based on an initial screening, Lutrol F68 was chosen as surfactant and high-shear homogenization as an emulsification method. A two-level fractional factorial design and an extended factorial design were employed to determine critical factors and best preparation conditions. Compritol concentration, l-leucine/lipid ratio, and Lutrol F68 concentration resulted critical. Best conditions granted 51% yield, 3.2 μm l-leucine/SLN particle size, and a SLN population around 150 nm. All samples showed the presence of lipid aggregates. Material loss in the emulsification step was found responsible for SLN aggregation and low yield. The almost quantitative Rp loading increased SLN population span. Replacing compritol with cetyl palmitate produced aggregation of dry powders and SLN. Overall, NSD was found a fast method to produce SLN dry powders. More insightful assessment of the emulsification step and lipid property effects will be critical to the optimization of the NSD process. Hypotheses account for direct coupling of high-pressure homogenization with NSD for future successful development of this promising manufacturing method.
Similar content being viewed by others
References
Mehnert W, Mäder K. Solid lipid nanoparticles. Adv Drug Deliv Rev [Internet]. 2012;64:83–101.
Shegokar R, Singh KK, Müller RH. Production & stability of stavudine solid lipid nanoparticles—from lab to industrial scale. Int J Pharm. 2011;416:461–70.
Patil H, Kulkarni V, Majumdar S, Repka MA. Continuous manufacturing of solid lipid nanoparticles by hot melt extrusion. Int J Pharm. 2014;471:153–6.
Radomskasoukharev A. Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev. 2007;59:411–8.
Salminen H, Helgason T, Aulbach S, Kristinsson B, Kristbergsson K, Weiss J. Influence of co-surfactants on crystallization and stability of solid lipid nanoparticles. J Colloid Interface Sci. 2014;426:256–63.
Blasi P, Giovagnoli S, Schoubben A, Ricci M, Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv Drug Deliv Rev. 2007;59:454–77.
Pietkiewicz J, Sznitowska M, Placzek M. The expulsion of lipophilic drugs from the cores of solid lipid microspheres in diluted suspensions and in concentrates. Int J Pharm. 2006;310:64–71.
Westesen K, Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm. 1995;115:129–31.
Trotta M, Cavalli R, Trotta C, Bussano R, Costa L. Electrospray technique for solid lipid-based particle production. Drug Dev Ind Pharm. 2010;36:431–8.
Campardelli R, Cherain M, Perfetti C, Iorio C, Scognamiglio M, Reverchon E, et al. Lipid nanoparticles production by supercritical fluid assisted emulsion–diffusion. J Supercrit Fluids. 2013;82:34–40.
Chattopahdyay P, Shekunov B, Yim D, Cipolla D, Boyd B, Farr S. Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system☆. Adv Drug Deliv Rev. 2007;59:444–53.
Freitas C, Müllerä RH. Spray-drying of solid lipid nanoparticles (SLN TM). Eur J Pharm Biopharm. 1998;46:145–51.
Gaspar DP, Serra C, Lino PR, Gonçalves L, Taboada P, Remuñán-López C, et al. Microencapsulated SLN: an innovative strategy for pulmonary protein delivery. Int J Pharm. 2017;516:231–46.
Di Sabatino M, Albertini B, Kett VL, Passerini N. Spray congealed lipid microparticles with high protein loading: preparation and solid state characterisation. Eur J Pharm Sci. 2012;46:346–56.
Cordeiro P, Temtem M, Winters C. Spray congealing: applications in the pharmaceutical industry. Chimica Oggi/Chemistry Today. 2013;31(5):69–72.
Wang T, Hu Q, Zhou M, Xue J, Luo Y. Preparation of ultra-fine powders from polysaccharide-coated solid lipid nanoparticles and nanostructured lipid carriers by innovative nano spray drying technology. Int J Pharm. 2016;511:219–22.
Wang T, Hu Q, Zhou M, Xia Y, Nieh M-P, Luo Y. Development of “all natural” layer-by-layer redispersible solid lipid nanoparticles by nano spray drying technology. Eur J Pharm Biopharm. 2016;107:273–85.
Heng D, Lee SH, Ng WK, Tan RB. The nano spray dryer B-90. Expert Opin Drug Deliv [Internet]. 2011;8:965–72 Available from: http://www.tandfonline.com/doi/full/10.1517/17425247.2011.588206.
Schmid K, Arpagaus C, Friess W. Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications. Pharm Dev Technol. 2011;16:287–94.
Oliveira AM, Guimaraes KL, Cerize NN, Tunussi AS, Poco JG. Nano spray drying as an innovative technology for encapsulating hydrophilic active pharmaceutical ingredients (API). J Nanomed Nanotechnol. 2013;4(6):186.
Derringer G, Suich R. Simultaneous optimization of several response variables. J Qual Technol. 1980;12:214–9.
Mazuryk J, Deptuła T, Polchi A, Gapiński J, Giovagnoli S, Magini A, et al. Rapamycin-loaded solid lipid nanoparticles: morphology and impact of the drug loading on the phase transition between lipid polymorphs. Colloids Surfaces A Physicochem Eng Asp. 2016;502:54–65.
Polchi A, Magini A, Mazuryk J, Tancini B, Gapiński J, Patkowski A, et al. Rapamycin loaded solid lipid nanoparticles as a new tool to deliver mTOR inhibitors: formulation and in vitro characterization. Nano. 2016;6:87.
Singh-Joy SD, McLain VC. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics. Int J Toxicol. 2008;27(Suppl. 2):93–128.
Pedroso JAB, Zampieri TT, Donato J Jr. Reviewing the effects of l-leucine supplementation in the regulation of food intake, energy balance, and glucose homeostasis. Nutrients. 2015;7(5):3914–37.
Acknowledgements
This work was partially performed at the University of Perugia Interdepartmental Laboratories of Nanomaterials (L.U.NA.).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 5140 kb)
Rights and permissions
About this article
Cite this article
Glaubitt, K., Ricci, M. & Giovagnoli, S. Exploring the Nano Spray-Drying Technology as an Innovative Manufacturing Method for Solid Lipid Nanoparticle Dry Powders. AAPS PharmSciTech 20, 19 (2019). https://doi.org/10.1208/s12249-018-1203-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-018-1203-0